News
AstraZeneca Monotherapy for Gastric Cancer Gains Third Approval in China
AstraZeneca and Daiichi Sankyo’s Enhertu has received conditional approval in China as a monotherapy for the treatment of adult patients with locally advanced or...
Drug Research
Nanoform and Takeda to Collaborate on Plasma-Derived Therapy Formulation
Nanoform Finland Plc , the medicine performance-enhancing company announced that it is to enter into a pre-clinical development agreement with the Plasma-derived Therapies Business...
Drug Research
Baxter Announces Definitive Agreement to Divest Its Vantive Kidney Care Segment to Carlyle for $3.8 Billion
Baxter International Inc., a global medtech leader, and funds managed by global investment firm Carlyle announced that they have signed a definitive agreement under...
Press Releases
Phastar named in 2024 Environment 100 List
Phastar, global specialist biometrics contract research organization (CRO), has been recognized in the 2024 Environment 100 List, led by Graham Clark. The award is...
Drug Research
Daiichi And MSD Broaden DXd ADC Collaboration Worldwide
Daiichi Sankyo and MSD have widened their partnership to create and market three DXd-based antibody-drug conjugates (ADCs) all over the world.
DXd is the name...
Drug Research
With a $400M Deal: Ideaya Targets Biocytogens BsADC Program
For an option on Biocytogen Pharmaceuticals' possible first-in-class B7H3/PTK7 BsADC program, Ideaya Biosciences is paying more than $400 million. The goal of antibody drug...
Drug Research
Eli Lilly Invests In Actinium-225 To Support Radiopharma
The largest pharmaceutical company in the world based on market value, Eli Lilly, is getting into the nuclear isotope manufacturing industry as cancer medicine...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read